Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Dec 16, 2022
Net Buying
Open-Market Buys
$211K
Open-Market Sells
$0
Net Open-Market Flow
$211K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2022Buy(P)28K$1.24$34K440K
Dec 14, 2022Buy(P)140K$1.26$176K4.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-035779) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML